Table 2.
Organizational resource needs, physician recruitment practices, and pharmacotherapy overall and by state
| Available N |
Mean (SD) or % (N) |
IQR | Florida Mean (SD) or % (N) |
Ohio Mean (SD) or % (N) |
Wisconsin Mean (SD) or % (N) |
|
|---|---|---|---|---|---|---|
| General Resource Needs | 150 | 4.4 (0.7) | 4.2, 5.0 | 4.6 (0.4) | 4.3 (0.7) | 4.3 (0.8) |
| Medical Resource Needs** | 158 | 3.9 (1.2) | 3.7, 5.0 | 3.3 (1.5) | 3.8 (1.2) | 4.2 (1.0) |
| Physician Outreach Activities | 157 | 2.2 (1.1) | 1.0, 3.0 | 2.5 (1.0) | 2.2 (0.9) | 2.2 (1.2) |
| Dedicated Resources for Recruitment** | 156 | 1.3 (1.4) | 1.0, 2.5 | 1.3 (0.9) | 1.6 (1.1) | 2.1 (1.6) |
| Provides buprenorphine-naloxone* | 158 | 55.7% (88) | 75.0% (18) | 62.8% (32) | 45.8% (38) | |
| Provides buprenorphine (without naloxone)* | 157 | 37.6% (59) | 58.3% (21) | 42.9% (21) | 28.6% (24) | |
| Provides oral naltrexone | 156 | 50.0% (78) | 45.8% (11) | 54.9% (27) | 48.9% (40) | |
| Provides extended-release naltrexone** | 156 | 65.4% (102) | 91.3% (21) | 68.0% (34) | 56.6% (47) | |
| Provides methadone*** | 155 | 14.2% (22) | 45.8% (11) | 12.2% (6) | 6.1% (5) | |
| Assigned buprenorphine slots | 151 | 84.5 (198.0) | 0.0, 100.0 | 92.1 (99.5) | 122.9 (292.6) | 61.3 (142.3) |
| Open buprenorphine slots (among the subset of organizations with any slots) | 83 | 71.3 (140.8) | 2.0, 95.0 | 93.6 (72.3) | 86.5 (215.5) | 47.9 (76.1) |
Notes. IQR=inter-quartile range. Significant F-statistic or chi-square test,
*
p<.05,
**
p<.01,
***
p<.001.